Article Text

Download PDFPDF

Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.
  1. P. S. Ganly,
  2. C. Arthur,
  3. J. M. Goldman,
  4. W. E. Schulenburg
  1. Department of Haematology, Hammersmith Hospital, London, UK.


    This report describes a patient with chronic granulocytic leukaemia who developed cataracts on busulphan treatment. Following allogeneic bone marrow transplantation, he developed cytomegalovirus retinitis, which was treated successfully with trisodium phosphonoformate (foscarnet). Cytomegalovirus retinitis and its therapy, and busulphan-induced cataract are discussed.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.